281 related articles for article (PubMed ID: 2936597)
21. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
Kurebayashi J; Horiuchi R; Nakamura T; Iino Y; Ishida T; Takigawa H; Izuo M
Nihon Naibunpi Gakkai Zasshi; 1987 Nov; 63(11):1351-63. PubMed ID: 2965035
[TBL] [Abstract][Full Text] [Related]
22. [Progestogen therapy in the treatment of endometrial cancer--clinical results and mechanism of steroid action].
Okada H
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):924-8. PubMed ID: 2968780
[TBL] [Abstract][Full Text] [Related]
23. Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells.
Levin JH; Tonetta SA; Lobo RA
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1932-8. PubMed ID: 2147816
[TBL] [Abstract][Full Text] [Related]
24. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
[TBL] [Abstract][Full Text] [Related]
25. Effect of progestin, antiprogestin, and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells.
Tseng L; Gao JG; Chen R; Zhu HH; Mazella J; Powell DR
Biol Reprod; 1992 Sep; 47(3):441-50. PubMed ID: 1380842
[TBL] [Abstract][Full Text] [Related]
26. [Growth inhibition by progestins in human endometrial cancer cells with progesterone receptors].
Tanizawa O; Terakawa N
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):917-23. PubMed ID: 3389835
[TBL] [Abstract][Full Text] [Related]
27. Progestin regulation of vascular endothelial growth factor in human breast cancer cells.
Hyder SM; Murthy L; Stancel GM
Cancer Res; 1998 Feb; 58(3):392-5. PubMed ID: 9458078
[TBL] [Abstract][Full Text] [Related]
28. Regulation of progesterone receptor messenger ribonucleic acid by progestin in human endometrial stromal cells.
Tseng L; Zhu HH
Biol Reprod; 1997 Dec; 57(6):1360-6. PubMed ID: 9408241
[TBL] [Abstract][Full Text] [Related]
29. Effect of estradiol and progesterone on human endometrial aromatase activity in primary cell culture.
Tseng L
Endocrinology; 1984 Aug; 115(2):833-5. PubMed ID: 6745184
[TBL] [Abstract][Full Text] [Related]
30. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
31. Progestin and antiprogestin effects on progesterone receptor transformation.
Spilman CH; Gibson RE; Beuving DC; Campbell JA
J Steroid Biochem; 1986 Jan; 24(1):383-9. PubMed ID: 2939296
[TBL] [Abstract][Full Text] [Related]
32. Progestin stimulates the biosynthesis of fibronectin and accumulation of fibronectin mRNA in human endometrial stromal cells.
Zhu HH; Huang JR; Mazela J; Elias J; Tseng L
Hum Reprod; 1992 Feb; 7(2):141-6. PubMed ID: 1533646
[TBL] [Abstract][Full Text] [Related]
33. Levonorgestrel, medroxyprogesterone and progesterone cause a concentration-dependent reduction in endometrial cancer (Ishikawa) cell density, and high concentrations of progesterone and mifepristone act in synergy.
Moe BT; Vereide AB; Orbo A; Jaeger R; Sager G
Anticancer Res; 2009 Apr; 29(4):1047-52. PubMed ID: 19414344
[TBL] [Abstract][Full Text] [Related]
34. The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17 beta-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study.
Mäentausta O; Svalander P; Danielsson KG; Bygdeman M; Vihko R
J Clin Endocrinol Metab; 1993 Oct; 77(4):913-8. PubMed ID: 8408465
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
[TBL] [Abstract][Full Text] [Related]
36. In vitro growth regulation of endometrial carcinoma cells by tamoxifen and medroxyprogesterone acetate.
Grenman SE; Roberts JA; England BG; Grönroos M; Carey TE
Gynecol Oncol; 1988 Jun; 30(2):239-50. PubMed ID: 2967231
[TBL] [Abstract][Full Text] [Related]
37. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells.
Schatz F; Papp C; Toth-Pal E; Lockwood CJ
J Clin Endocrinol Metab; 1994 Jun; 78(6):1467-72. PubMed ID: 8200951
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Fujimoto J; Fujita H; Hosoda S; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
[TBL] [Abstract][Full Text] [Related]
39. Regulation of insulin-like growth factor-binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells.
Bell SC; Jackson JA; Ashmore J; Zhu HH; Tseng L
J Clin Endocrinol Metab; 1991 May; 72(5):1014-24. PubMed ID: 1708779
[TBL] [Abstract][Full Text] [Related]
40. In vitro characterization of trimegestone: a new potent and selective progestin.
Zhang Z; Lundeen SG; Zhu Y; Carver JM; Winneker RC
Steroids; 2000; 65(10-11):637-43. PubMed ID: 11108870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
